AJP - Renal Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol 271: F961-F966, 1996;
0363-6127/96 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Simon, D. B.
Right arrow Articles by Lifton, R. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Simon, D. B.
Right arrow Articles by Lifton, R. P.

AJP - Renal Physiology, Vol 271, Issue 5 961-F966, Copyright © 1996 by American Physiological Society


ARTICLES

The molecular basis of inherited hypokalemic alkalosis: Bartter's and Gitelman's syndromes

D. B. Simon and R. P. Lifton
Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, Connecticut 06510, USA.

Hypokalemic alkalosis with low blood pressure can be caused by a number of medications or alternatively as an autosomal recessive genetic trait. Molecular genetic approaches to this problem have recently demonstrated that mutations in genes encoding the thiazide-sensitive Na-Cl cotransporter or the bumetanide-sensitive Na-K-2Cl cotransporter produce two distinctive clinical and physiological pictures featuring hypokalemic alkalosis. Mutations in the latter cause a phenotypic picture called Bartter's syndrome that includes marked hypercalciuria and neonatal presentation with marked intravascular volume depletion. Mutations in the former cotransporter result in Gitelman's syndrome, which includes hypocalciuria, hypomagnesemia, and typically older clinical presentation with predominant muscular signs and symptoms. These findings establish the molecular basis of these disorders and indicate that the diverse abnormalities seen in affected patients derive from primary defects in these mediators of cotransport function. Moreover, these findings have implications for normal mechanisms of renal electrolyte homeostasis and for potential phenotypic effects in the more common heterozygous carriers of these mutations.


This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
C.-T. Lee, H.-C. Chen, L.-W. Lai, K.-C. Yong, and Y.-H. H. Lien
Effects of furosemide on renal calcium handling
Am J Physiol Renal Physiol, October 1, 2007; 293(4): F1231 - F1237.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
D. T. WARD, S. K. YAU, A. P. MEE, E. B. MAWER, C. A. MILLER, H. O. GARLAND, and D. RICCARDI
Functional, Molecular, and Biochemical Characterization of Streptozotocin-Induced Diabetes
J. Am. Soc. Nephrol., April 1, 2001; 12(4): 779 - 790.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
L.-J. Dai, G. Ritchie, D. Kerstan, H. S. Kang, D. E. C. Cole, and G. A. Quamme
Magnesium Transport in the Renal Distal Convoluted Tubule
Physiol Rev, January 1, 2001; 81(1): 51 - 84.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
J. P. Rapp
Genetic Analysis of Inherited Hypertension in the Rat
Physiol Rev, January 1, 2000; 80(1): 135 - 172.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
D. Reimann and P. Gross
Chronic, diagnosis-resistant hypokalaemia
Nephrol. Dial. Transplant., December 1, 1999; 14(12): 2957 - 2961.
[Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
S. N. Orlov, N. C. Adragna, V. A. Adarichev, and P. Hamet
Genetic and biochemical determinants of abnormal monovalent ion transport in primary hypertension
Am J Physiol Cell Physiol, March 1, 1999; 276(3): C511 - C536.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
J. C COBETA-GARCIA, A. GASCÓN, E. IGLESIAS, and V. ESTOPIÑÁN
Chondrocalcinosis and Gitelman's syndrome. A new association?
Ann Rheum Dis, December 1, 1998; 57(12): 748 - 749.
[Full Text]


Home page
Am. J. Physiol. Renal Physiol.Home page
L.-J. Dai, B. Bapty, G. Ritchie, and G. A. Quamme
PGE2 stimulates Mg2+ uptake in mouse distal convoluted tubule cells
Am J Physiol Renal Physiol, November 1, 1998; 275(5): F833 - F839.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. J. Schultheis, J. N. Lorenz, P. Meneton, M. L. Nieman, T. M. Riddle, M. Flagella, J. J. Duffy, T. Doetschman, M. L. Miller, and G. E. Shull
Phenotype Resembling Gitelman's Syndrome in Mice Lacking the Apical Na+-Cl- Cotransporter of the Distal Convoluted Tubule
J. Biol. Chem., October 30, 1998; 273(44): 29150 - 29155.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
G. G. MacGregor, J. Z. Xu, C. M. McNicholas, G. Giebisch, and S. C. Hebert
Partially active channels produced by PKA site mutation of the cloned renal K+ channel, ROMK2 (kir1.2)
Am J Physiol Renal Physiol, September 1, 1998; 275(3): F415 - F422.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
F. J. Gennari
Hypokalemia
N. Engl. J. Med., August 13, 1998; 339(7): 451 - 458.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online